CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Henan Lingrui Pharmaceutical Co., Ltd. Company Snapshot
Henan Lingrui Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Henan Lingrui Pharmaceutical Co., Ltd. with three other companies in this sector in China: Tianjin Tianyao Pharmaceutical, Ltd. (2017 sales of 1.97 billion Chinese Renmimbi [US$286.67 million] ), Hainan Haiyao Company Limited (1.82 billion Chinese Renmimbi [US$265.27 million] of which 77% was BPC), and Zhejiang Jiuzhou Pharmaceutical Co Ltd (1.72 billion Chinese Renmimbi [US$249.70 million] of which 92% was Production and sale of chemical active p).

Sales Analysis. Henan Lingrui Pharmaceutical Co., Ltd. reported sales of 1.85 billion Chinese Renmimbi (US$268.76 million) for the year ending December of 2017. This represents an increase of 28.5% versus 2016, when the company's sales were 1.44 billion Chinese Renmimbi. Sales at Henan Lingrui Pharmaceutical Co., Ltd. have increased during each of the previous five years (and since 2012, sales have increased a total of 229%). Sales of Healthcare saw an increase of 28.5% in 2017, from 1.42 billion Chinese Renmimbi to 1.83 billion Chinese Renmimbi. Not all segments of Henan Lingrui Pharmaceutical Co., Ltd. experienced an increase in sales in 2017: sales of Other fell 24.9% to 23.02 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Henan Lingrui Pharmaceutical Co., Ltd.
  Stock Performance Chart for Henan Lingrui Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (8/17/2018): 9.08
(Figures in Chinese Renmimbi)
1 Week -4.2%   13 Weeks -6.4%  
4 Weeks -9.7%   52 Weeks -17.5%  
 
Henan Lingrui Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600285 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 1,848,525,085
(Year Ending Jan 2018).
Employees: 2,436
  Currency: Chinese Renmimbi Market Cap: 5,378,273,209
  Fiscal Yr Ends: December Shares Outstanding: 592,320,838
  Share Type: A Gu Closely Held Shares: 202,456,328
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.